Thomas Catinazzo Net Worth & Insider Trades
Thomas Catinazzo - Chief Financial Officer, Relay Therapeutics, Inc
What is Thomas Catinazzo's Net Worth?
The current estimated net worth of Relay Therapeutics, Inc's Chief Financial Officer, Thomas Catinazzo, is estimated to be about $4.66M . Thomas Catinazzo owns about 144,145 units of Relay Therapeutics, Inc common stock. In the last 3 years at Relay Therapeutics, Inc, Thomas Catinazzo has sold an estimated value of $4.54M worth.
What is Thomas Catinazzo's Past Insider Trading?
Thomas Catinazzo's largest purchase order was 26,257 units , worth over $108.18K on September 8, 2022. Thomas Catinazzo's largest sale order was 22,500 units , worth over $796.5K on November 16, 2021. In total, Thomas Catinazzo has made about 27 transactions over 3 years of their time at Relay Therapeutics, Inc. Thomas Catinazzo usually trades in September, with the busiest year in 2022. The most recent transaction was a sale order of 1,697 units , worth over $10.23K on November 1, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Thomas Catinazzo
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Thomas Catinazzo's' Mailing Address?
- Mailing address is C/o Relay Therapeutics, Inc. 399 Binney Street Cambridge MA 02139 MA
Relay Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Sanjiv K. Patel, M.D. | 2020 | $585,000 | $7,965,341 | $402,188 | - | $8,952,529 |
| Sanjiv K. Patel, M.D. | 2019 | $585,000 | $2,590,671 | $353,925 | - | $3,529,596 |
| Donald Bergstrom M.D., Ph.D. | 2020 | $440,000 | $1,339,104 | $220,000 | $9,816 | $2,008,920 |
| Donald Bergstrom M.D., Ph.D. | 2019 | $406,850 | $330,652 | $179,014 | - | $916,516 |
| Brian R. Adams | 2020 | $390,000 | $714,193 | $170,625 | $7,428 | $1,282,246 |
| Brian R. Adams | 2019 | $356,213 | $165,326 | $97,958 | - | $619,497 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1812364/000156459021018016/rlay-def14a_20210519.htm
What are Relay Therapeutics, Inc's Past Insider Trades?
Relay Therapeutics, Inc's most recent insider trade came on November 1, 2023 by Peter Rahmer who sold 1,354 units worth $8.16K . In the last 3 years, insiders at Relay Therapeutics, Inc have sold an estimated value of $251.12M and bought an estimated value of $5.32M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Donald Bergstrom, President, Brian Adams, Chief Legal Officer, and Thomas Catinazzo, Chief Financial Officer .
Relay Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||